Език: EN EN
← Назад към резултатите
Набира участници NCT02848274

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Заболявания: Mycosis Fungoides Non-Hodgkin's Lymphoma

Спонсор: Stanford University

Налично на: БГ
Обобщение
The purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various institutions. The investigators hope this will enable the identification of low- and high-risk groups for survival in order to improve patient care and outcome.
Кой може да участва
Inclusion Criteria * Diagnosis of advanced stage MF or SS (Stages IIB - IVB) within 6 months of presentation to the participating center * Patients that are expected to have care administered at the participating center or jointly with referring physician(s) where follow-up data would be available Exclusion Criteria * Patients diagnosed with early stage MF/SS (Stages IA-IIA) before progressing to advanced stage * Patients diagnosed with advanced MF/SS more than 6 months prior to initial presentation to the participating center * Exclude one-time consultation type of new patients.
Места на провеждане 7
Argentina (1)
Hospital Italiano de Buenos Aires
Buenos Aires
Австралия (1)
Peter MacCallum Cancer Center,
Melbourne
Бразилия (1)
University of Sao Paulo Medical School
São Paulo
Jose Sanches, MD
Китай (1)
Peking University First Hospital
Beijing
Япония (1)
The University of Tokyo
Tokyo
Tomomitsu Miyagaki
Великобритания (1)
University Hospitals Birmingham
Birmingham
САЩ (1)
City of Hope
Duarte , California
Christiane Querfeld
Технически детайли
Статус
Набира участници
Вид изследване
OBSERVATIONAL
Пол
Мъже и жени
Здрави доброволци
Не
Начална дата
01.10.2016
Крайна дата
01.03.2027
Регистрационен номер
NCT02848274
Източник
anzctr
Запитване за медицински туризъм

Информацията е извлечена автоматично от ClinicalTrials.gov. Консултирайте се с вашия лекар преди да предприемете действия.